Richards, N. J., Alqallaf, A., Mitchell, R. D., Parnell, A., Haidar, H. B., Almeida, J. R., Williams, J., Vijayakumar, P., Balogun, A., Matsakas, A., Trim, S. A., Patel, K. and Vaiyapuri, S.
ORCID: https://orcid.org/0000-0002-6006-6517
(2023)
Indian ornamental tarantula (Poecilotheria regalis) venom affects myoblast function and causes skeletal muscle damage.
Cells, 12 (16).
2074.
ISSN 2073-4409
doi: 10.3390/cells12162074
Abstract/Summary
Envenomation by the Indian ornamental tarantula (Poecilotheria regalis) is medically relevant to humans, both in its native India and worldwide, where they are kept as pets. Muscle-related symptoms such as cramps and pain are commonly reported in humans following envenomation by this species. There is no specific treatment including antivenom for its envenomation. Moreo-ver, the scientific knowledge on the impact of this venom on skeletal muscle function is highly limited. Therefore, we carried out this study to better understand the myotoxic properties of Poe-cilotheria regalis venom by determining its effects in cultured myoblasts and in the tibialis anteri-or muscle in mice. While there was no effect found on undifferentiated myoblasts, the venom af-fected differentiated multinucleated myotubes resulting in the inhibition of fusion and atrophy of myotubes. Similarly, intramuscular administration of this venom in the tibialis anterior muscle in mice resulted in extensive muscle damage on day 5. However, by day 10, the regeneration was evident, and the regeneration process was continuing until day 20. Nevertheless, some tissue ab-normalities including reduced dystrophin expression and microthrombi presence were observed on day 20. Overall, this study demonstrates the ability of this venom to induce significant muscle damage and affect its regeneration in the early stages. These data provide novel mechanistic in-sights into this venom-induced muscle damage and guide future studies to isolate and character-ise individual toxic component(s) that induce muscle damage and their significance in developing better therapeutics.
Altmetric Badge
| Additional Information | A correction to this article was published on 27/01/2025 and is available here https://doi.org/10.3390/cells14030191 |
| Item Type | Article |
| URI | https://reading-clone.eprints-hosting.org/id/eprint/113016 |
| Identification Number/DOI | 10.3390/cells12162074 |
| Refereed | Yes |
| Divisions | Life Sciences > School of Biological Sciences > Biomedical Sciences Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy > Division of Pharmacology |
| Additional Information | A correction to this article was published on 27/01/2025 and is available here https://doi.org/10.3390/cells14030191 |
| Publisher | MDPI |
| Download/View statistics | View download statistics for this item |
Downloads
Downloads per month over past year
University Staff: Request a correction | Centaur Editors: Update this record
Download
Download